Nicole Donaldson
Family Medicine · Norfolk, VANPI 1396062931
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.2% of the total across 98 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 15.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $518 and has fallen 86.5% since, to $70 in 2023.
Across 98 payments — averaging $16.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$257
- Amgen$252
- Arbor Pharmaceuticals, Inc.$223
- AbbVie$174
- Novartis$169
- Boehringer Ingelheim$121
- plus $446 from 16 others
What the payments were for
- Food & beverage$1,61198%
- Education$302%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 18 | $257 |
| Amgen | 16 | $252 |
| Arbor Pharmaceuticals, Inc. | 11 | $223 |
| AbbVie(2 entities) | 9 | $174 |
| Novartis | 9 | $169 |
| Boehringer Ingelheim | 6 | $121 |
| E.r. Squibb & Sons, L.L.C. | 5 | $69 |
| Sanofi-aventis U.S. LLC | 3 | $57 |
| Astellas Pharma US Inc | 3 | $51 |
| Pfizer | 3 | $43 |
| Merck | 2 | $27 |
| Novo Nordisk | 2 | $26 |
| GSK | 2 | $25 |
| Braemar Manufacturing, LLC | 1 | $21 |
| Bayer | 1 | $21 |
| Preventice Services, LLC | 1 | $19 |
| Amarin Pharma, Inc. | 1 | $19 |
| Vifor Pharma, Inc. | 1 | $16 |
| Lundbeck LLC | 1 | $14 |
| Johnson & Johnson | 1 | $12 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $12 |
| Esperion Therapeutics, Inc. | 1 | $12 |
How this compares
$1,641 in reported general payments places this provider in the 75th percentile of 2,553 family medicine providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nifedipine ErNifedipine | 22 | $921 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $495 |
| Atorvastatin Calcium | 41 | $485 |
| Losartan Potassium | 26 | $275 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 29 | $239 |
| Omeprazole | 16 | $227 |
| Simvastatin | 16 | $171 |
| Levothyroxine Sodium | 13 | $149 |
| Rosuvastatin Calcium | 13 | $129 |
| Lisinopril | 15 | $125 |
| Hydralazine Hcl | 12 | $119 |
| Trazodone Hcl | 15 | $109 |
| Amlodipine Besylate | 25 | $72 |
| Metformin Hcl ErMetformin Hcl | 18 | $59 |
| Hydrochlorothiazide | 19 | $41 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Norfolk
- Monique MatuskowitzNorfolk$110K
- Oluwaronke AwosikaFort Gregg Adams$397K
- Paul StairsRichmond$105K
- Edwin RobinsonRichmond$83K
- Benjamin PhilpottRocky Mount$64K
- John MolaiyArlington$64K
- Catherine VarneyZion Crossroads$47K
- Jordan TranWinchester$42K
- John ClayColonial Heights$40K
- Thomas RobesonNewport News$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.